tradingkey.logo
tradingkey.logo
Search

Sarepta Therapeutics Inc

SRPT
Add to Watchlist
20.720USD
-0.200-0.96%
Close 09-15 16:00ET
2.19BMarket Cap
33.27P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-0.96%

5 Days

-1.05%

1 Month

+14.48%

6 Months

+26.34%

Year to Date

-3.72%

1 Year

+18.60%

Key Figures

20.810Open
21.060High
210.10KVolume
33.27P/E TTM
26.01P/E Dynamic
--Dividend TTM
0.20%Turnover Ratio
20.920Prev. Close
20.290Low
4.36MTurnover
9.31P/E Static
1.43P/B
0.00%Div Yield TTM
1.96%ROA
25.32052wk High
24.65Volume Ratio
235.24MNet Profit
105.62MShares
0.6231EPS TTM
0.21Beta
4.91%ROE
14.68052wk Low
3.47%Amplitude
77.07%Gross Margin
2.19BMarket Cap
1.92Reward/Risk
5.11%Risk Rate

Sarepta Therapeutics Inc's Score

0.05vs previous score
Forecast6.59
Financial Health7.30
Technical5.02
Valuation Dimensions8.73
Institutional Confidence10.00
Risk Assessment4.77

Media Coverage

Coverage Level

Very Low
Very High
Negative

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
HoldCurrent Rating
22.509Target Price
+10.07%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy66555544
Buy33333333
Hold1212141414141415
Sell55544444
Strong Sell11111111

Sarepta Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Sell

Summary

Neutral

Moving Average

Buy

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.05/0.26
Revenue / Forecast
401.25M/364.34M

Sarepta Therapeutics Inc Profile

SectorPharmaceuticals
Ticker SymbolSRPT
Number of employees1372
CountryUnited States of America

Ownership

ShareholdersProportion
BlackRock Institutional Trust Company, N.A.11.89%
AQR Capital Management, LLC7.38%
Vanguard Portfolio Management, LLC6.29%
State Street Investment Management (US)6.25%
Shareholder TypesProportion
Investment Advisor41.23%
Investment Advisor/Hedge Fund28.79%
Hedge Fund11.54%
Research Firm6.41%

FAQs

What is the current price of Sarepta Therapeutics Inc (SRPT)?

The current price of Sarepta Therapeutics Inc (SRPT) is 20.72.

What is the symbol of Sarepta Therapeutics Inc?

The ticker symbol of Sarepta Therapeutics Inc is SRPT.

What is the 52-week high of Sarepta Therapeutics Inc?

The 52-week high of Sarepta Therapeutics Inc is 25.32.

What is the 52-week low of Sarepta Therapeutics Inc?

The 52-week low of Sarepta Therapeutics Inc is 14.68.

What is the market capitalization of Sarepta Therapeutics Inc?

The market capitalization of Sarepta Therapeutics Inc is 2.19B.

Is Sarepta Therapeutics Inc (SRPT) currently rated as Buy, Hold, or Sell?

According to analysts, Sarepta Therapeutics Inc (SRPT) has an overall rating of signal_hold, with a price target of 22.51.

What is the Earnings Per Share (EPS TTM) of Sarepta Therapeutics Inc (SRPT)?

The Earnings Per Share (EPS TTM) of Sarepta Therapeutics Inc (SRPT) is 0.62.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.